S. J. Lee, « American Society of Clinical Oncology Recommendations on Fertility Preservation in Cancer Patients, J. Clin. Oncol, vol.24, pp.2917-2931, 2006.

M. Comtet, C. Sonigo, C. Valdelièvre, N. Sermondade, C. Sifer et al., « Préservation de la fertilité dans le cancer du sein : où en est-on en 2014 ?, Bull. Cancer (Paris), vol.102, issue.5, pp.443-453, 2015.

J. Bénard, J. Calvo, M. Comtet, A. Benoit, C. Sifer et al., « Préservation de la fertilité chez la femme en âge de procréer : indications et stratégies, J. Gynécologie Obstétrique Biol. Reprod, vol.45, issue.5, pp.424-444, 2016.

, Code de la santé publique-Article L2141-11, pp.2141-2152

C. «-plan, Ref : PLANKPNRT14 | Institut National Du Cancer, 2014.

. Isfp-practice-committee, « Recommendations for fertility preservation in patients with lymphoma, leukemia, and breast cancer, J. Assist. Reprod. Genet, vol.29, issue.6, pp.465-468

«. Committee-opinion and . No, Oocyte Cryopreservation, vol.584, pp.221-222, 2014.

F. Cardoso, « The European Society of Breast Cancer Specialists recommendations for the management of young women with breast cancer », Eur. J. Cancer Oxf. Engl, vol.48, pp.3355-3377, 1990.

K. M. Ataya, J. A. Mckanna, A. M. Weintraub, M. R. Clark, and W. J. Lemaire, « A Luteinizing Hormone-releasing Hormone Agonist for the Prevention of Chemotherapyinduced Ovarian Follicular Loss in Rats, Cancer Res, vol.45, issue.8, pp.3651-3656, 1985.

W. J. Gradishar and R. L. Schilsky, « Ovarian function following radiation and chemotherapy for cancer, Semin. Oncol, vol.16, issue.5, pp.425-436, 1989.

D. Meirow, H. Biederman, R. A. Anderso-n-,-e-t, and W. H. , Chemotherapy and Radiation on Female Reproduction, vol.53, issue.4, pp.727-739, 2010.

L. Kalich-philosoph, Burnout"; AS101 Prevents Follicle Loss and Preserves Fertility, Sci. Transl. Med, vol.5, pp.185-62, 2013.

D. Meirow, M. Epstein, H. Lewis, D. Nugent, and R. G. Gosden, « Administration of cyclophosphamide at different stages of follicular maturation in mice: effects on reproductive performance and fetal malformations, Hum. Reprod. Oxf. Engl, vol.16, issue.4, pp.632-637, 2001.

W. H. Wallace, S. M. Shalet, J. H. Hendry, P. H. Morris-jones, and H. R. Gattamaneni, Ovarian failure following abdominal irradiation in childhood: the radiosensitivity of the human oocyte, vol.62, pp.995-998, 1989.

W. H. Wallace, R. A. Anderson, and D. S. Irvine, « Fertility preservation for young patients with cancer: who is at risk and what can be offered?, Lancet Oncol, vol.6, issue.4, pp.209-218, 2005.

E. C. Larsen, K. Schmiegelow, C. Rechnitzer, A. Loft, J. Müller et al., « Radiotherapy at a young age reduces uterine volume of childhood cancer survivors, Acta Obstet. Gynecol. Scand, vol.83, issue.1, pp.96-102, 2004.

K. A. Rodriguez-wallberg and K. Oktay, « Fertility preservation medicine: options for young adults and children with cancer, J. Pediatr. Hematol. Oncol, vol.32, issue.5, pp.390-396, 2010.

E. Muñoz, « Oocyte donation outcome after oncological treatment in cancer survivors, Fertil. Steril, vol.103, issue.1, pp.205-213, 2015.

J. Donnez, B. Martinez-madrid, P. Jadoul, A. Van-langendonckt, D. Demylle et al., Ovarian tissue cryopreservation and transplantation: a review, vol.12, pp.519-535, 2006.

H. O. Critchley and W. H. Wallace, « Impact of cancer treatment on uterine function, J. Natl. Cancer Inst. Monogr, vol.34, pp.64-68, 2005.

, « Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15year survival: an overview of the randomised trials, Lancet Lond. Engl, vol.365, pp.1687-1717, 2005.

C. Davies, « Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial, Lancet Lond. Engl, vol.381, pp.805-816, 2013.

J. A. Petrek, « Incidence, time course, and determinants of menstrual bleeding after breast cancer treatment: a prospective study, J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol, vol.24, issue.7, pp.1045-1051, 2006.

M. E. Abusief, S. A. Missmer, E. S. Ginsburg, J. C. Weeks, and A. H. Partridge, « The effects of paclitaxel, dose density, and trastuzumab on treatment-related amenorrhea in premenopausal women with breast cancer, Cancer, vol.116, issue.4, pp.791-798, 2010.

J. C. Berger and C. L. Clericuzio, « Pierre Robin sequence associated with first trimester fetal tamoxifen exposure, Am. J. Med. Genet. A, vol.146, pp.2141-2144, 2008.

K. J. Ruddy, Chemotherapy-related amenorrhea after adjuvant paclitaxeltrastuzumab (APT trial), vol.151, pp.589-596, 2015.

J. M. Letourneau, « Pre-treatment fertility counseling and fertility preservation improve quality of life in reproductive age women with cancer, Cancer, vol.118, issue.6, pp.1710-1717, 2012.

F. J. Broekmans, M. R. Soules, and B. C. Fauser, « Ovarian aging: mechanisms and clinical consequences », Endocr. Rev, vol.30, issue.5, pp.465-493, 2009.

J. M. Letourneau, « Acute ovarian failure underestimates age-specific reproductive impairment for young women undergoing chemotherapy for cancer, Cancer, vol.118, issue.7, pp.1933-1939, 2012.

S. M. Nelson, « Biomarkers of ovarian response: current and future applications, Fertil. Steril, vol.99, issue.4, pp.963-969, 2013.

K. L. Singh, Predictors of ovarian reserve in young women with breast cancer, vol.96, pp.1808-1816, 2007.

B. Yu, « Changes in markers of ovarian reserve and endocrine function in young women with breast cancer undergoing adjuvant chemotherapy, Cancer, vol.116, issue.9, pp.2099-2105, 2010.

A. Weghofer, W. Dietrich, D. H. Barad, and E. N. Gleicher, « Live birth chances in women with extremely low-serum anti-Mullerian hormone levels, Hum. Reprod. Oxf. Engl, vol.26, issue.7, pp.1905-1909, 2011.

A. W. Loren, « Fertility Preservation for Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update, J. Clin. Oncol, vol.31, pp.2500-2510, 2013.

J. D. Kort, M. L. Eisenberg, L. S. Millheiser, and L. M. Westphal, « Fertility issues in cancer survivorship », CA. Cancer J. Clin, vol.64, issue.2, pp.118-134, 2014.

B. Gerber, « Effect of luteinizing hormone-releasing hormone agonist on ovarian function after modern adjuvant breast cancer chemotherapy: the GBG 37 ZORO study, J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol, vol.29, pp.2334-2341, 2011.

A. Badawy, A. Elnashar, M. El-ashry, and E. M. Shahat, « Gonadotropin-releasing hormone agonists for prevention of chemotherapy-induced ovarian damage: prospective randomized study, Fertil. Steril, vol.91, issue.3, pp.694-697, 2009.

K. Oktay, M. Sönmezer, O. Oktem, K. Fox, G. Emons et al., « Abse nce of conclusive evidence for the safety and efficacy of gonadotropin-releasing hormone analogue treatment in protecting against chemotherapy-induced gonadal injury, The Oncologist, vol.12, issue.9, pp.1055-1066, 2007.

L. C. Hickman, N. C. Llarena, L. N. Valentine, X. Liu, and E. T. Falcone, « Preservation of gonadal function in women undergoing chemotherapy: a systematic review and meta-analysis of the potential role for gonadotropin-releasing hormone agonists, J. Assist. Reprod. Genet, vol.35, issue.4, pp.571-581, 2018.

K. Oktay, « Fertility Preservation in Patients With Cancer: ASCO Clinical Practice Guideline Update, J. Clin. Oncol, p.10

M. Kurt, G. Uncu, S. K. Cetintas, N. Kucuk, S. Guler et al., « Successful spontaneous pregnancy in a patient with rectal carcinoma treated with pelvic radiotherapy and concurrent chemotherapy: the unique role of laparoscopic lateral ovary transposition », Eur. J. Gynaecol. Oncol, vol.28, issue.5, pp.408-410, 2007.

R. A. Cowles, R. M. Gewanter, and J. J. Kandel, « Ovarian repositioning in pediatric cancer patients: Flexible techniques accommodate pelvic radiation fields, Pediatr. Blood Cancer, vol.49, issue.3, pp.339-341, 2007.

R. S. Williams, R. D. Littell, and N. P. Mendenhall, Laparoscopic oophoropexy and ovarian function in the treatment of Hodgkin disease, Cancer, vol.86, issue.10, pp.2138-2142, 1999.

K. Fujiwara, H. Mohri, T. Yoshida, H. Yamauchi, and E. I. Kohno, « Subcutaneous transposition of the ovary following hysterectomy, Int. J. Gynaecol. Obstet. Off. Organ Int. Fed. Gynaecol. Obstet, vol.58, issue.2, pp.223-228, 1997.

W. Gareer, Z. Gad, and H. Gareer, « Needle oophoropexy: a new simple technique for ovarian transposition prior to pelvic irradiation, Surg. Endosc, vol.25, issue.7, pp.2241-2246, 2011.

K. Gubbala, A. Laios, I. Gallos, P. Pathiraja, K. Haldar et al., « Outcomes of ovarian transposition in gynaecological cancers; a systematic review and metaanalysis, J. Ovarian Res, vol.7, issue.1, p.69, 2014.

I. Fernandez-pineda, « Impact of ovarian transposition before pelvic irradiation on ovarian function among long-term survivors of childhood Hodgkin lymphoma: A report from the St, Jude Lifetime Cohort Study », Pediatr. Blood Cancer, vol.65, issue.9, p.27232, 2018.

P. Morice, « Laparoscopic ovarian transposition for pelvic malignancies: indications and functional outcomes, Fertil. Steril, vol.70, issue.5, pp.956-960, 1998.

J. Donnez, M. Dolmans, and . Fertility, N. Engl. J. Med, vol.377, pp.1657-1665, 2017.

J. Donnez, « Livebirth after orthotopic transplantation of cryopreserved ovarian tissue, Lancet Lond. Engl, vol.364, pp.1405-1410, 2004.

P. , « Efficacy of ovarian tissue cryopreservation for fertility preservation: lessons learned from 545 cases, Hum. Reprod. Oxf. Engl, vol.32, issue.5, pp.1046-1054, 2017.

J. Y. Huang, T. Tulandi, H. Holzer, S. L. Tan, and R. Chian, « Combining ovarian tissue cryobanking with retrieval of immature oocytes followed by in vitro maturation and vitrification: an additional strategy of fertility preservation, Fertil. Steril, vol.89, issue.3, pp.567-572, 2008.

M. Dolmans, V. Luyckx, J. Donnez, C. Y. Andersen, and E. T. Greve, « Risk of transferring malignant cells with transplanted frozen-thawed ovarian tissue, Fertil. Steril, vol.99, issue.6, pp.1514-1522, 2013.

K. Winkler-crepaz, S. Ayuandari, S. C. Ziehr, S. Hofer, and E. L. Wildt, « Fertility preservation in cancer survivors, Minerva Endocrinol, vol.40, issue.2, pp.105-118, 2015.

H. Creux, P. Monnier, W. Son, T. Tulandi, and E. W. Buckett, « Immature oocyte retrieval and in vitro oocyte maturation at different phases of the menstrual cycle in women with cancer who require urgent gonadotoxic treatment, Fertil. Steril, vol.107, issue.1, pp.198-204, 2017.

E. Maman, D. Meirow, M. Brengauz, H. Raanani, J. Dor et al., « Luteal phase oocyte retrieval and in vitro maturation is an optional procedure for urgent fertility preservation, Fertil. Steril, vol.95, issue.1, pp.64-67, 2011.

H. Yin, H. Jiang, S. G. Kristensen, and C. Y. Andersen, « Vitrification of in vitro matured oocytes collected from surplus ovarian medulla tissue resulting from fertility preservation of ovarian cortex tissue, J. Assist. Reprod. Genet, vol.33, issue.6, pp.741-746, 2016.

E. B. Prasath, « First pregnancy and live birth resulting from cryopreserved embryos obtained from in vitro matured oocytes after oophorectomy in an ovarian cancer patient, Hum. Reprod. Oxf. Engl, vol.29, issue.2, pp.276-278, 2014.

H. Shirasawa and Y. Terada, « In vitro maturation of human immature oocytes for fertility preservation and research material, Reprod. Med. Biol, vol.16, issue.3, pp.258-267, 2017.

Z. Yang and R. Chian, « Development of in vitro maturation techniques for clinical applications, Fertil. Steril, vol.108, issue.4, pp.577-584, 2017.

P. E. Levi-setti, P. Patrizio, and E. G. Scaravelli, « Evolution of human oocyte cryopreservation: slow freezing versus vitrification, Curr. Opin. Endocrinol. Diabetes Obes, vol.23, issue.6, pp.445-450, 2016.

N. Potdar, T. A. Gelbaya, and L. G. Nardo, « Oocyte vitrification in the 21st century and post-warming fertility outcomes: a systematic review and meta-analysis, Reprod. Biomed. Online, vol.29, issue.2, pp.159-176, 2014.

S. Duros, C. Vinolas, M. Comtet, C. Sifer, and M. Grynberg, « Préservation de la fertilité féminine, Médecine Reprod, vol.20, issue.1, pp.4-10, 2018.

D. Stoop, « Reproductive potential of a metaphase II oocyte retrieved after ovarian stimulation: an analysis of 23 354 ICSI cycles, Hum. Reprod. Oxf. Engl, vol.27, issue.7, pp.2030-2035, 2012.

L. Rienzi, « Consistent and predictable delivery rates after oocyte vitrification: an observational longitudinal cohort multicentric study, Hum. Reprod. Oxf. Engl, vol.27, issue.6, pp.1606-1612

A. Cobo, J. A. García-velasco, A. Coello, J. Domingo, A. Pellicer et al., « Oocyte vitrification as an efficient option for elective fertility preservation, Fertil. Steril, vol.105, issue.3, pp.755-764, 2016.

J. O. Doyle, K. S. Richter, J. Lim, R. J. Stillman, J. R. Graham et al., « Successful elective and medically indicated oocyte vitrification and warming for autologous in vitro fertilization, with predicted birth probabilities for fertility preservation according to number of cryopreserved oocytes and age at retrieval, Fertil. Steril, vol.105, issue.2, pp.459-466, 2016.

C. Vinolas, J. Raad, C. Sonigo, C. Sifer, N. Sermondade et al., « Medical techniques of fertility preservation in the male and female, J. Visc. Surg, vol.155, pp.3-9, 2018.

A. Cobo, V. Serra, N. Garrido, I. Olmo, A. Pellicer et al., Fertil. Steril, vol.102, issue.4, pp.1006-1015, 2014.

S. Friedler, O. Koc, Y. Gidoni, A. Raziel, and R. Ron-el, « Ovarian response to stimulation for fertility preservation in women with malignant disease: a systematic review and meta-analysis », Fertil. Steril, vol.97, issue.1, pp.125-133

A. Agarwal and T. M. Said, Implications of systemic malignancies on human fertility, vol.9, pp.673-679, 2004.

L. , « Malignancy may adversely influence the quality and behaviour of oocytes, Hum. Reprod. Oxf. Engl, vol.13, issue.7, pp.1837-1840, 1998.

M. Das, F. Shehata, A. Moria, H. Holzer, W. Son et al., « Ovarian reserve, response to gonadotropins, and oocyte maturity in women with malignancy, Fertil. Steril, vol.96, issue.1, pp.122-125, 2011.

J. M. Knopman, N. Noyes, S. Talebian, L. C. Krey, J. A. Grifo et al., « Women with cancer undergoing ART for fertility preservation: a cohort study of their response to exogenous gonadotropins, Fertil. Steril, vol.91, issue.4, pp.1476-1478, 2009.

A. D. Robertso-n, S. A. Missm-er, and E. E. , Ginsb urg, « Embryo yield after in vitro fertilization in women undergoing embryo banking for fertility preservation before chemotherapy, Fertil. Steril, vol.95, issue.2, pp.588-591, 2011.

S. C. Klock, J. X. Zhang, and R. R. Kazer, « Fertility preservation for female cancer patients: early clinical experience, Fertil. Steril, vol.94, issue.1, pp.149-155, 2010.

S. Lee and K. Oktay, « Does higher starting dose of FSH stimulation with letrozole improve fertility preservation outcomes in women with breast cancer?, Fertil. Steril, vol.98, issue.4, pp.961-964, 2012.

M. P. Rosen, E. Johnstone, C. Addauan-andersen, and E. M. , Cedars, « A lower antral follicle count is associated with infertility, Fertil. Steril, vol.95, issue.6, pp.1950-1954, 1954.

, « Les spécificités des cancers des enfants et des adolescents-Cancérologie pédiatrique | Institut National Du Cancer

C. A. Sklar, « Premature menopause in survivors of childhood cancer: a report from the childhood cancer survivor study, J. Natl. Cancer Inst, vol.98, issue.13, pp.890-896, 2006.

M. Wolff, T. Bruckner, T. Strowitzki, and E. A. Germeyer, « Fertility preservation: ovarian response to freeze oocytes is not affected by different malignant diseasesan analysis of 992 stimulations, J. Assist. Reprod. Genet, 2018.

, Projection de l'incidence et de la mortalité par cancer en France métropolitaine en 2017 / 2018 / Maladies chroniques et traumatismes / Rapports et synthèses / Publications et outils / Accueil

A. Gougeon, « Regulation of ovarian follicular development in primates: facts and hypotheses, Endocr. Rev, vol.17, issue.2, pp.121-155, 1996.

A. H. Partridge and E. P. Winer, Long-term complications of adjuvant chemotherapy for early stage breast cancer, vol.21, pp.55-64, 2004.

M. J. Hayat, N. Howlader, M. E. Reichman, and B. K. Edwards, « Cancer statistics, trends, and multiple primary cancer analyses from the Surveillance, Epidemiology, and End Results (SEER) Program », The Oncologist, vol.12, issue.1, pp.20-37, 2007.

B. Gerber, M. Dieterich, H. Müller, and E. T. Reimer, « Controversies in preservation of ovary function and fertility in patients with breast cancer, Breast Cancer Res. Treat, vol.108, issue.1, pp.1-7, 2008.

L. Del-mastro and M. Lambertini, Gonadotropin-releasing hormone analogs for ovarian function protection during chemotherapy in young early breast cancer patients: the last piece of the puzzle?, Ann. Oncol. Off. J. Eur. Soc. Med. Oncol, vol.28, issue.8, pp.1683-1685, 2017.

K. A. Rodriguez-wallberg, S. Eloranta, K. Krawiec, A. Lissmats, J. Bergh et al., « Safety of fertility preservation in breast cancer patients in a registerbased matched cohort study, Breast Cancer Res. Treat, vol.167, issue.3, pp.761-769, 2018.

R. J. Rodgers, « The safety and efficacy of controlled ovarian hyperstimulation for fertility preservation in women with early breast cancer: a systematic review, Hum. Reprod. Oxf. Engl, vol.32, issue.5, pp.1033-1045, 2017.

A. A. Azim, M. Costantini-ferrando, and E. K. Oktay, « Safety of fertility preservation by ovarian stimulation with letrozole and gonadotropins in patients with breast cancer: a prospective controlled study, J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol, vol.26, pp.2630-2635, 2008.

J. Kim, V. Turan, K. Oktay, and . Long, Term Safety of Letrozole and Gonadotropin Stimulation for Fertility Preservation in Women With Breast Cancer, J. Clin. Endocrinol. Metab, vol.101, issue.4, pp.1364-1371, 2016.

K. Oktay, « Letrozole reduces estrogen and gonadotropin exposure in women with breast cancer undergoing ovarian stimulation before chemotherapy, J. Clin. Endocrinol. Metab, vol.91, issue.10, pp.3885-3890, 2006.

T. Dahhan, E. Balkenende, M. Van-wely, S. Linn, and M. Goddijn, « Tamoxifen or letrozole versus standard methods for women with estrogen-receptor positive breast cancer undergoing oocyte or embryo cryopreservation in assisted reproduction, Cochrane Database Syst. Rev, issue.11, p.10240, 2013.

K. Oktay, E. Buyuk, N. Libertella, M. Akar, and E. Z. Rosenwaks, « Fertility preservation in breast cancer patients: a prospective controlled comparison of ovarian stimulation with tamoxifen and letrozole for embryo cryopreservation, J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol, vol.23, pp.4347-4353, 2005.

C. Decanter, F. Morschhauser, P. Pigny, C. Lefebvre, C. Gallo et al., Müllerian hormone follow-up in young women treated by chemotherapy for lymphoma: preliminary results, Reprod. Biomed. Online, vol.20, issue.2, pp.280-285, 2010.

M. Wolff, M. Montag, R. Dittrich, D. Denschlag, F. Nawroth et al., « Fertility preservation in women-a practical guide to preservation techniques and therapeutic strategies in breast cancer, Hodgkin's lymphoma and borderline ovarian tumours by the fertility preservation network FertiPROTEKT, Arch. Gynecol. Obstet, vol.284, issue.2, pp.427-435, 2011.

K. T. Schmidt and C. Y. Andersen, et ISFP Practice Committee, « Recommendations for fertility preservation in patients with lymphomas, J. Assist. Reprod. Genet, vol.29, issue.6, pp.473-477

B. Lawrenz, « Reduced pretreatment ovarian reserve in premenopausal female patients with Hodgkin lymphoma or non-Hodgkin-lymphoma-evaluation by using antimüllerian hormone and retrieved oocytes, Fertil. Steril, vol.98, issue.1, pp.141-144, 2012.

A. W. Loren, « Fertility preservation for patients with cancer: American Society of Clinical Oncology clinical practice guideline update, J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol, vol.31, pp.2500-2510, 2013.

L. J. Heffner, Advanced maternal age-how old is too old?, N. Engl. J. Med, vol.351, 1927.

D. E. Reichman, O. K. Davis, N. Zaninovic, Z. Rosenwaks, and D. E. Goldschlag, « Fertility preservation using controlled ovarian hyperstimulation and oocyte cryopreservation in a premenarcheal female with myelodysplastic syndrome, Fertil. Steril, vol.98, issue.5, pp.1225-1228, 2012.

L. Del-pup, F. Salvagno, A. Borini, M. Trovò, and F. A. Peccatori, « Ovarian transposition in young women and fertility sparing », Eur. Rev. Med. Pharmacol. Sci, vol.20, issue.2, pp.197-198, 2016.

A. Dezellus, « Prospective evaluation of serum anti-Müllerian hormone dynamics in 250 women of reproductive age treated with chemotherapy for breast cancer », Eur. J. Cancer Oxf. Engl, vol.79, pp.72-80, 1990.

A. Wenners, « Reduced ovarian reserve in young early breast cancer patients: preliminary data from a prospective cohort trial, BMC Cancer, vol.17, issue.1, p.632, 2017.

A. Perdrix, « Influence of adjuvant chemotherapy on anti-Müllerian hormone in women below 35 years treated for early breast cancer, Reprod. Biomed. Online, vol.35, issue.4, pp.468-474, 2017.

C. Decanter, « Toward a better follow-up of ovarian recovery in young women after chemotherapy with a hypersensitive antimüllerian hormone assay, Fertil. Steril, vol.102, issue.2, pp.483-487, 2014.

C. Simon, Analyse des valeurs seuils de compte des follicules antraux et d'hormone Anti-Müllérienne sérique permettant de prédire le nombre d'ovocytes cryopréservés en maturation in vitro chez des jeunes femmes atteintes de cancer et candidates à une préservation de la fertilité, 2015.

R. A. Anderson, R. T. Mitchell, T. W. Kelsey, N. Spears, E. E. Telfer et al., « Cancer treatment and gonadal function: experimental and established strategies for fertility preservation in children and young adults, Lancet Diabetes Endocrinol, vol.3, issue.7, pp.556-567, 2015.

K. Yu, S. Huang, J. Zhang, G. Liu, and Z. Shao, « Association between delayed initiation of adjuvant CMF or anthracycline-based chemotherapy and survival in breast cancer: a systematic review and meta-analysis, BMC Cancer, vol.13, p.240, 2013.

Y. Kuang, « Double stimulations during the follicular and luteal phases of poor responders in IVF/ICSI programmes (Shanghai protocol), Reprod. Biomed. Online, vol.29, issue.6, pp.684-691, 2014.

A. Vaiarelli, « Double Stimulation in the Same Ovarian Cycle (DuoStim) to Maximize the Number of Oocytes Retrieved From Poor Prognosis Patients: A Multicenter Experience and SWOT Analysis, Front. Endocrinol, vol.9, p.317, 2018.

F. M. Ubaldi, « Follicular versus luteal phase ovarian stimulation during the same menstrual cycle (DuoStim) in a reduced ovarian reserve population results in a similar euploid blastocyst formation rate: new insight in ovarian reserve exploitation, Fertil. Steril, vol.105, issue.6, pp.1488-1495, 2016.

S. Logan, J. Perz, J. Ussher, M. Peate, and E. A. Anazodo, « Clinician provision of oncofertility support in cancer patients of a reproductive age: A systematic review, Psycho-Oncology, vol.27, issue.3, pp.748-756, 2018.

A. H. Partridge, « Web-based survey of fertility issues in young women with breast cancer, J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol, vol.22, pp.4174-4183, 2004.

M. Wolff, « Ovarian stimulation to cryopreserve fertilized oocytes in cancer patients can be started in the luteal phase, Fertil. Steril, vol.92, issue.4, pp.1360-1365, 2009.

K. P. Mcnatty, « Hormonal correlates of follicular development in the human ovary, Aust. J. Biol. Sci, vol.34, issue.3, pp.249-268, 1981.

G. P. Adams, R. L. Matteri, J. P. Kastelic, J. C. Ko, and O. J. Ginther, « Association between surges of follicle-stimulating hormone and the emergence of follicular waves in heifers, J. Reprod. Fertil, vol.94, issue.1, pp.177-188, 1992.

G. P. Adams, J. Singh, and A. R. Baerwald, « Large animal models for the study of ovarian follicular dynamics in women, Theriogenology, vol.78, issue.8, pp.1733-1748, 2012.

A. R. Baerwald, G. P. Adams, and R. A. Pierson, A new model for ovarian follicular development during the human menstrual cycle, Fertil. Steril, vol.80, issue.1, pp.116-122, 2003.

P. H. De-mello and . Bianchi, Review: follicular waves in the human ovary: a new physiological paradigm for novel ovarian stimulation protocols, vol.17, pp.1067-1076, 2010.

A. R. Baerwald, G. P. Adams, and R. A. Pierson, Characterization of Ovarian Follicular Wave Dynamics in Women1, vol.69, pp.1023-1031, 2003.

N. Qin, « Flexibility in starting ovarian stimulation at different phases of the menstrual cycle for treatment of infertile women with the use of in vitro fertilization or intracytoplasmic sperm injection, Fertil. Steril, vol.106, issue.2, pp.334-341, 2016.

H. Cakmak and M. P. Rosen, Random-start ovarian stimulation in patients with cancer, vol.27, pp.215-221, 2015.

M. Wolff, E. Capp, J. Jauckus, T. Strowitzki, and E. A. Germeyer, « Timing of ovarian stimulation in patients prior to gonadotoxic therapy: an analysis of 684 stimulations », Eur. J. Obstet. Gynecol. Reprod. Biol, vol.199, pp.146-149, 2016.

M. A. Checa, « Random-start GnRH antagonist for emergency fertility preservation: a self-controlled trial, International Journal of Women's Health, pp.12-2015

G. Simi, M. E. Obino, E. Casarosa, P. Litta, P. G. Artini et al., « Different stimulation protocols for oocyte cryropreservation in oncological patients: a retrospective analysis of single university centre, Gynecol. Endocrinol, vol.31, pp.966-970, 2015.

R. A. Anderson, D. Kinniburgh, and D. T. Baird, « Preliminary experience of the use of a gonadotrophin-releasing hormone antagonist in ovulation induction/in-vitro fertilization prior to cancer treatment, Hum. Reprod. Oxf. Engl, vol.14, issue.10, pp.2665-2668, 1999.

H. Cakmak, A. Katz, M. I. Cedars, and M. P. Rosen, « Effective method for emergency fertility preservation: random-start controlled ovarian stimulation, Fertil. Steril, vol.100, issue.6, pp.1673-1680, 2013.

V. Turan, G. Bedoschi, F. Moy, and E. K. Oktay, « Safety and feasibility of performing two consecutive ovarian stimulation cycles with the use of letrozole-gonadotropin protocol for fertility preservation in breast cancer patients, Fertil. Steril, vol.100, issue.6, pp.1681-1685, 2013.

F. Martínez, « Comparison of starting ovarian stimulation on day 2 versus day 15 of the menstrual cycle in the same oocyte donor and pregnancy rates among the corresponding recipients of vitrified oocytes, Fertil. Steril, vol.102, issue.5, pp.1307-1311, 2014.

H. Chen, « Comparison of live-birth defects after luteal-phase ovarian stimulation vs. conventional ovarian stimulation for in vitro fertilization and vitrified embryo transfer cycles, Fertil. Steril, vol.103, issue.5, pp.1194-1201, 2015.

A. Madrigrano, L. Westphal, and E. I. Wapnir, « Egg retrieval with cryopreservation does not delay breast cancer treatment, Am. J. Surg, vol.194, issue.4, pp.477-481, 2007.

J. M. Letourneau, « Random start ovarian stimulation for fertility preservation appears unlikely to delay initiation of neoadjuvant chemotherapy for breast cancer, Hum. Reprod, vol.32, issue.10, pp.2123-2129, 2017.

M. Zizi, Préservation de la fertilité: évaluation des connaissances et des pratiques des médecins ayant une activité oncologique en territoire d'Aquitaine », Thèse d'exercice, p.98, 2017.

S. Hippocrate,

, Mon premier souci sera de rétablir, de préserver ou de promouvoir la santé dans tous ses éléments, physiques et mentaux

, Je respecterai toutes les personnes, leur autonomie et leur volonté?,volonté?, sans aucune discrimina on selon leur état ou leurs convictions. J'interviendrai pour les protéger si elles sont affaiblies, vulnérables ou menacées dans leur intégritéóu leur dignité?.dignité?. Même sous la contrainte, je ne ferai pas usage de mes connaissances contre les lois de l'humanité?.humanité?. J'informerai les parents des décisions envisagées

, Admise dans l'intimité?desintimité?des personnes, je tairai les secrets qui me seront confiés. Reçue à l'intérieur des maisons, je respecterai les secrets des foyers et ma conduite ne servira pas à corrompre les moeurs

, Je ferai tout pour soulager les souffrances. Je ne prolongerai pas abusivement les agonies. Je ne provoquerai jamais la mort délibérément

, Je n'entreprendrai rien qui dépasse mes compétences. Je les entretiendrai et les perfectionnerai pour assurer au mieux les services qui me seront demandés

, J'apporterai mon aide à mes confrères ainsi qu'à leurs familles dans l'adversité?.adversité?

, Que les hommes et mes confrères m'accordent leur estime si je suis fidèle à mes promesses ; que je sois déshonorée et méprisée si j'y manque